首页> 外文OA文献 >Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive Study

【2h】

Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive Study

机译：甲状腺功能障碍与抗岩VEGFR2结合单克隆抗体Ramucirumab：一系列14例和描述性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Satoshi Dote; Daisuke Yamaguchi; Daiki Hira; Satoshi Noda; Yuka Kobayashi; Tomohiro Terada;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive Study [J] . Biological & pharmaceutical bulletin . 2020,第4期

机译：甲状腺功能障碍与抗岩VEGFR2结合单克隆抗体Ramucirumab：一系列14例和描述性研究
2. Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab [J] . Arnold, Fuchs, C.S., Annals of oncology: official journal of the European Society for Medical Oncology . 2017,第12期

机译：从六种随机安慰剂对照试验的术语分析与抗血管生成VEGFR2结合单克隆抗体Ramucirumab的单一患者安全性数据分析
3. Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling: In Vitro Evaluation on VEGFR2-positive Cell Lines [J] . Janousek Jiri, Barta Pavel, Novy Zbynek, Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第2期

机译：抗易生人单克隆抗体Ramucirumab放射性标签：在VEGFR2阳性细胞系上进行体外评价
4. An anti-MUC1 monoclonal antibody for radioimmunoscintigraphy of breastcancer: indirect labeling of antibody via the HYNIC with 99mTc; in vitro and invivo studies of new radiopharmaceutical [C] . M.Salouti, H.Rajabi, H.Babaei, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：用于乳腺癌放射免疫显像的抗MUC1单克隆抗体：通过HYNIC间接标记99mTc的抗体;新放射性药物的体外和体内研究
5. Development and Characterization of Novel Anti-bat Monoclonal Antibodies for Studying Bat Immunity [D] . Cowan, Cailyn. 2017

机译：研究蝙蝠免疫的新型抗蝙蝠单克隆抗体的开发与表征
6. Meta-analysis of individual patient safety data from six randomized placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab [O] . D Arnold, C S Fuchs, J Tabernero, -1

机译：使用抗血管生成性VEGFR2结合单克隆抗体ramucirumab进行的六项随机安慰剂对照试验的个体患者安全性数据的荟萃分析
7. Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab [O] . D. Arnold, C.S. Fuchs, J. Tabernero, 2017

机译：来自六种随机的安慰剂对照试验的个体患者安全数据的荟萃分析，其与抗血管生成VEGFR2结合单克隆抗体Ramucirumab
8. Monoclonal Antibodies and Cancer. Studies on the Use of Monoclonal Antibodies for Imaging and Therapy of Cancer, with Special Emphasis on Ovarian Carcinoma [R] . Haisma, H. J. 1987

机译：单克隆抗体和癌症。单克隆抗体在癌症成像和治疗中的应用研究，特别强调卵巢癌

Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive Study

著录项

引文网络

相似文献

相关主题

期刊订阅